Stephen Neeleman - HealthEquity Vice Chairman of the Board, Founder
| HQY Stock | USD 105.61 1.84 1.71% |
Chairman
Dr. Stephen D. Neeleman, M.D., is Vice Chairman of the Board, Founder of the Company. Dr. Neeleman founded HealthEquity in 2002 and has served as our Vice Chairman since February 2014, having previously served as our President and Chief Executive Officer from November 2002 through January 2014 and as a director since November 2002. Dr. Neeleman is a board certified general surgeon and practiced for Intermountain Healthcare American Fork Hospital in American Fork, Utah, from November 2009 to December 2014. Dr. Neeleman is the coauthor of The Complete HSA GuidebookHow to Make Health Savings Accounts Work for You and a contributor to Dr. Clayton M. Christensen The Innovator PrescriptionA Disruptive Solution for Health Care. While on the faculty of the University of Arizona Department of Surgery, Dr. Neeleman was involved with the initial passage of the legislation authorizing HSAs. Prior to attending medical school, Dr. Neeleman worked as a senior manager for Morris Air . He serves on the America Health Insurance Plans HSA Leadership Council since 2014.
| Age | 57 |
| Tenure | 11 years |
| Professional Marks | Ph.D |
| Address | 15 West Scenic Pointe Drive, Draper, UT, United States, 84020 |
| Phone | 801 727 1000 |
| Web | https://www.healthequity.com |
Latest Insider Transactions
Neeleman holds a B.A. from Utah State University and an M.D. from the University of Utah, and completed his surgical residency at the University of Arizona. The board of directors believes that Dr. Neeleman experience in the healthcare industry as a medical doctor, his expertise in the history, development and administration of HSAs, and his extensive knowledge of our company as its founder qualify him to serve on our board of directors.Stephen Neeleman Latest Insider Activity
Tracking and analyzing the buying and selling activities of Stephen Neeleman against HealthEquity stock is an integral part of due diligence when investing in HealthEquity. Stephen Neeleman insider activity provides valuable insight into whether HealthEquity is net buyers or sellers over its current business cycle. Note, HealthEquity insiders must abide by specific rules, including filing SEC forms every time they buy or sell HealthEquity'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Stephen Neeleman over three months ago Acquisition by Stephen Neeleman of 24188 shares of HealthEquity at 14.0 subject to Rule 16b-3 | ||
Stephen Neeleman over six months ago Disposition of 5348 shares by Stephen Neeleman of HealthEquity at 80.6151 subject to Rule 16b-3 |
HealthEquity Management Efficiency
The company has Return on Asset of 0.0379 % which means that on every $100 spent on assets, it made $0.0379 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.047 %, implying that it generated $0.047 on every 100 dollars invested. HealthEquity's management efficiency ratios could be used to measure how well HealthEquity manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to 0.13 in 2025, whereas Return On Capital Employed is likely to drop 0.05 in 2025. At this time, HealthEquity's Total Assets are fairly stable compared to the past year. Other Current Assets is likely to rise to about 58.6 M in 2025, whereas Other Assets are likely to drop 1.09 in 2025.Similar Executives
| Found 1 records | CHAIRMAN Age | ||
| David Paul | Globus Medical | 58 | |
Management Performance
| Return On Equity | 0.047 | ||||
| Return On Asset | 0.0379 |
HealthEquity Leadership Team
Elected by the shareholders, the HealthEquity's board of directors comprises two types of representatives: HealthEquity inside directors who are chosen from within the company, and outside directors, selected externally and held independent of HealthEquity. The board's role is to monitor HealthEquity's management team and ensure that shareholders' interests are well served. HealthEquity's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, HealthEquity's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Cheryl King, Executive Officer | ||
| Elimelech Rosner, Executive CTO | ||
| Tia Padia, Executive Officer | ||
| Richard Putnam, IR Contact Officer | ||
| Larry Trittschuh, Executive Vice President Chief Security Officer | ||
| James Lucania, CFO VP | ||
| Delano JD, General VP | ||
| Jon Kessler, CEO and President and Director | ||
| Angelique Hill, Executive Vice President - Operations | ||
| Darcy Mott, CFO, Executive VP and Treasurer | ||
| Stephen Neeleman, Vice Chairman of the Board, Founder | ||
| Delano Ladd, Executive Vice President General Counsel and Corporate Secretary | ||
| Brad Bennion, Senior Development | ||
| Scott JD, President CEO | ||
| Tyson Murdock, Ex CFO | ||
| Steve Lindsay, Executive Management | ||
| Kamesh Tumsi, Senior Product |
HealthEquity Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is HealthEquity a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.047 | ||||
| Return On Asset | 0.0379 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.18 % | ||||
| Current Valuation | 9.97 B | ||||
| Shares Outstanding | 86.66 M | ||||
| Shares Owned By Insiders | 2.68 % | ||||
| Shares Owned By Institutions | 97.32 % | ||||
| Number Of Shares Shorted | 4.4 M | ||||
| Price To Earning | 525.29 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for HealthEquity Stock Analysis
When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.